Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased MtDNA Integrity

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Dec 29

PMID 28030582

Citations 35

Authors

Kaytee L Pokrzywinski

Thomas G Biel

Dmitry Kryndushkin

V Ashutosh Rao

Affiliations

Soon will be listed here.

Abstract

Mitochondrial dysregulation is closely associated with excessive reactive oxygen species (ROS) production. Altered redox homeostasis has been implicated in the onset of several diseases including cancer. Mitochondrial DNA (mtDNA) and proteins are particularly sensitive to ROS as they are in close proximity to the respiratory chain (RC). Mitoquinone (MitoQ), a mitochondria-targeted redox agent, selectively damages breast cancer cells possibly through damage induced via enhanced ROS production. However, the effects of MitoQ and other triphenylphosphonium (TPP+) conjugated agents on cancer mitochondrial homeostasis remain unknown. The primary objective of this study was to determine the impact of mitochondria-targeted agent [(MTAs) conjugated to TPP+: mitoTEMPOL, mitoquinone and mitochromanol-acetate] on mitochondrial physiology and mtDNA integrity in breast (MDA-MB-231) and lung (H23) cancer cells. The integrity of the mtDNA was assessed by quantifying the degree of mtDNA fragmentation and copy number, as well as by measuring mitochondrial proteins essential to mtDNA stability and maintenance (TFAM, SSBP1, TWINKLE, POLG and POLRMT). Mitochondrial status was evaluated by measuring superoxide production, mitochondrial membrane depolarization, oxygen consumption, extracellular acidification and mRNA or protein levels of the RC complexes along with TCA cycle activity. In this study, we demonstrated that all investigated MTAs impair mitochondrial health and decrease mtDNA integrity in MDA-MB-231 and H23 cells. However, differences in the degree of mitochondrial damage and mtDNA degradation suggest unique properties among each MTA that may be cell line, dose and time dependent. Collectively, our study indicates the potential for TPP+ conjugated molecules to impair breast and lung cancer cells by targeting mitochondrial homeostasis.

Citing Articles

Mitochondrial Aconitase and Its Contribution to the Pathogenesis of Neurodegenerative Diseases.

Padalko V, Posnik F, Adamczyk M Int J Mol Sci. 2024; 25(18).

PMID: 39337438 PMC: 11431987. DOI: 10.3390/ijms25189950.

Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth.

Wang H, Liu Y, Lu X, Wu Y, Gu W, Yin G Cell Death Dis. 2024; 15(9):643.

PMID: 39227564 PMC: 11372113. DOI: 10.1038/s41419-024-07023-8.

Mitochondrial DNA-targeted therapy: A novel approach to combat cancer.

Lin Y, Yang B, Huang Y, Zhang Y, Jiang Y, Ma L Cell Insight. 2023; 2(4):100113.

PMID: 37554301 PMC: 10404627. DOI: 10.1016/j.cellin.2023.100113.

Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies.

Cheng G, Karoui H, Hardy M, Kalyanaraman B Free Radic Biol Med. 2023; 205:175-187.

PMID: 37321281 PMC: 11129726. DOI: 10.1016/j.freeradbiomed.2023.06.009.

Understanding the Pathogenesis of Cardiac Complications in Patients with Propionic Acidemia and Exploring Therapeutic Alternatives for Those Who Are Not Eligible or Are Waiting for Liver Transplantation.

Maines E, Moretti M, Vitturi N, Gugelmo G, Fasan I, Lenzini L Metabolites. 2023; 13(4).

PMID: 37110221 PMC: 10143878. DOI: 10.3390/metabo13040563.

References

El-Hattab A, Scaglia F . Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics. 2013; 10(2):186-98. PMC: 3625391. DOI: 10.1007/s13311-013-0177-6. View

Wojtala A, Bonora M, Malinska D, Pinton P, Duszynski J, Wieckowski M . Methods to monitor ROS production by fluorescence microscopy and fluorometry. Methods Enzymol. 2014; 542:243-62. DOI: 10.1016/B978-0-12-416618-9.00013-3. View

Gane E, Weilert F, Orr D, Keogh G, Gibson M, Lockhart M . The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 2010; 30(7):1019-26. DOI: 10.1111/j.1478-3231.2010.02250.x. View

Wanrooij S, Falkenberg M . The human mitochondrial replication fork in health and disease. Biochim Biophys Acta. 2010; 1797(8):1378-88. DOI: 10.1016/j.bbabio.2010.04.015. View

Harman D . Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298-300. DOI: 10.1093/geronj/11.3.298. View

Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C . Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc. 2012; 7(6):1235-46. DOI: 10.1038/nprot.2012.058. View

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

Murphy M, Smith R . Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2006; 47:629-56. DOI: 10.1146/annurev.pharmtox.47.120505.105110. View

Kuhl I, Kukat C, Ruzzenente B, Milenkovic D, Mourier A, Miranda M . POLRMT does not transcribe nuclear genes. Nature. 2014; 514(7521):E7-11. DOI: 10.1038/nature13690. View

10.

Shadel G . Mitochondrial DNA, aconitase 'wraps' it up. Trends Biochem Sci. 2005; 30(6):294-6. DOI: 10.1016/j.tibs.2005.04.007. View

11.

Nicholls T, Minczuk M . In D-loop: 40 years of mitochondrial 7S DNA. Exp Gerontol. 2014; 56:175-81. DOI: 10.1016/j.exger.2014.03.027. View

12.

Shokolenko I, Venediktova N, Bochkareva A, Wilson G, Alexeyev M . Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 2009; 37(8):2539-48. PMC: 2677867. DOI: 10.1093/nar/gkp100. View

13.

Miquel J . An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutat Res. 1992; 275(3-6):209-16. DOI: 10.1016/0921-8734(92)90024-j. View

14.

Spelbrink J, Li F, Tiranti V, Nikali K, Yuan Q, Tariq M . Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 2001; 28(3):223-31. DOI: 10.1038/90058. View

15.

Chen X, Wang X, Kaufman B, Butow R . Aconitase couples metabolic regulation to mitochondrial DNA maintenance. Science. 2005; 307(5710):714-7. DOI: 10.1126/science.1106391. View

16.

Tyynismaa H, Sembongi H, Bokori-Brown M, Granycome C, Ashley N, Poulton J . Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum Mol Genet. 2004; 13(24):3219-27. DOI: 10.1093/hmg/ddh342. View

17.

Paramasivam A, Meena A, Pedaparthi L, Jyothi V, Uppin M, Jabeen S . Novel mutation in C10orf2 associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging. Mitochondrion. 2015; 26:81-5. DOI: 10.1016/j.mito.2015.12.006. View

18.

Beckham T, Lu P, Jones E, Marrison T, Lewis C, Cheng J . LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. J Pharmacol Exp Ther. 2012; 344(1):167-78. PMC: 3533418. DOI: 10.1124/jpet.112.199216. View

19.

Cheng G, Zielonka J, McAllister D, Craig MacKinnon Jr A, Joseph J, Dwinell M . Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. BMC Cancer. 2013; 13:285. PMC: 3686663. DOI: 10.1186/1471-2407-13-285. View

20.

Enright H, MILLER W, Hays R, Floyd R, Hebbel R . Preferential targeting of oxidative base damage to internucleosomal DNA. Carcinogenesis. 1996; 17(5):1175-7. DOI: 10.1093/carcin/17.5.1175. View